P

PharmaResearch Co Ltd
KOSDAQ:214450

Watchlist Manager
PharmaResearch Co Ltd
KOSDAQ:214450
Watchlist
Price: 434 500 KRW -1.25%
Market Cap: 4.5T KRW

Intrinsic Value

The intrinsic value of one PharmaResearch Co Ltd stock under the Base Case scenario is 535 585.21 KRW. Compared to the current market price of 434 500 KRW, PharmaResearch Co Ltd is Undervalued by 19%.

Intrinsic Value
535 585.21 KRW
Undervaluation 19%
Intrinsic Value
Price
P
Worst Case
Base Case
Best Case

Valuation History
PharmaResearch Co Ltd

What is Valuation History?
Ask AI Assistant
What other research platforms think about PharmaResearch Co Ltd?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is PharmaResearch Co Ltd valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for PharmaResearch Co Ltd.

Explain Valuation
Compare PharmaResearch Co Ltd to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about PharmaResearch Co Ltd?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
PharmaResearch Co Ltd

Current Assets 612.9B
Cash & Short-Term Investments 481.1B
Receivables 65.1B
Other Current Assets 66.7B
Non-Current Assets 310.3B
Long-Term Investments 101.1B
PP&E 164.6B
Intangibles 34.5B
Other Non-Current Assets 10.2B
Current Liabilities 79.7B
Accounts Payable 9.1B
Short-Term Debt 100m
Other Current Liabilities 70.4B
Non-Current Liabilities 232B
Long-Term Debt 200B
Other Non-Current Liabilities 32B
Efficiency

Free Cash Flow Analysis
PharmaResearch Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
PharmaResearch Co Ltd

Revenue
449.8B KRW
Cost of Revenue
-117B KRW
Gross Profit
332.9B KRW
Operating Expenses
-163.6B KRW
Operating Income
169.2B KRW
Other Expenses
-42.2B KRW
Net Income
127B KRW
Fundamental Scores

Profitability Score
Profitability Due Diligence

PharmaResearch Co Ltd's profitability score is 68/100. The higher the profitability score, the more profitable the company is.

Exceptional ROIC
Positive 3Y Average ROIC
ROIC is Increasing
Exceptional Operating Margin
68/100
Profitability
Score

PharmaResearch Co Ltd's profitability score is 68/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

PharmaResearch Co Ltd's solvency score is 92/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Short-Term Solvency
Low D/E
92/100
Solvency
Score

PharmaResearch Co Ltd's solvency score is 92/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
PharmaResearch Co Ltd

Wall Street analysts forecast PharmaResearch Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PharmaResearch Co Ltd is 838 542 KRW with a low forecast of 797 900 KRW and a high forecast of 934 500 KRW.

Lowest
Price Target
797 900 KRW
84% Upside
Average
Price Target
838 542 KRW
93% Upside
Highest
Price Target
934 500 KRW
115% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for PharmaResearch Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one PharmaResearch Co Ltd stock?

The intrinsic value of one PharmaResearch Co Ltd stock under the Base Case scenario is 535 585.21 KRW.

Is PharmaResearch Co Ltd stock undervalued or overvalued?

Compared to the current market price of 434 500 KRW, PharmaResearch Co Ltd is Undervalued by 19%.

Back to Top